1Analysis of the judgement and consideration application of rules for supplementary experimental data in pharmaceutical field from administrative and judicial perspectivesGENG Sheng-yan1121-11272Strategic adaptation mechanisms of traditional Chinese medicine enterprises in Southeast Asian markets:a study based on game theoryFANG Zhong-jian, SHI Cheng-ling, CUI Li-you, CHEN Li-ping, MA Yong-zhe, LU Jun-wen, FANG Hai-cheng, FAN Yu-lu1128-11373Radionuclide selection,conjugation strategies,and CMC considerations for quality control differences in radionuclide drug conjugatesDAI Yi-fei, XIE Yu-jia, JIANG Tao, TU Zhi-jun, WANG Ming-hong, REN Feng1138-11444General considerations for the CMC research of immune cell therapy products during the investigational new drugCHEN Chao, XU Hui-nan, PAN Jing, SHEN Bo1145-11515Research progress on natural polysaccharide-based microneedles and their mediated nanodelivery systemsGUO Yu-shan, ZHANG Ai-lin, LIU Yu-tong, TONG Da-peng, MEI Yu-tong, WANG Yan-hong1152-11606Research progress on Bupleuri Radix and its active components in prevention and treatment of major depressive disorderZHANG Ru, SUO Xin, LIU Wen-rong, LI Ying-mei, WANG Shui-xiang, DOU Xia, YANG Xin-rong, JIN Zi-ming1161-11677Research progress on measurement methods of glomerular filtration rateZHANG Yan-mei, ZHOU Chang-hui, SU Hong-yan, YANG Bin, LU Yan-xin, LI Hua1168-11748Progress in researches for sublingual tablets in emergency treatment of cardiac and cerebral ischemic infarctionXU Jian-pei, ZHU Shun-wei, CHEN Rong, XU Shan-seng, REN Jian, WANG Lan, WANG Feng1175-11829Analysis of the current situation and characteristics of clinical trials of traditional Chinese medicine in ChinaYANG Jia-pei, WU Wei, LU Xiu-hua, FAN Hong-yan1183-118710Preparation and characterization of doxorubicin-loaded quercetin metal complex targeting nanoparticlesCHEN Lin-wan, WANG Zhou-li, CHEN Wei-jun, QIU Li-peng, WANG Dong-kai1188-119911Research on the mechanism of hippocampal CA3 synaptic plasticity in diabetes mellitus with depression based on P2X7/NLRP3 signaling in microglia of the DG regionWANG Ting-ting, ZOU Man-shu, GUO Hai-peng, YU Xiao-shi, ZHANG Yao, XIANG Zi-xuan, SU Hai-long, WANG Yu-hong, HAN Yuan-shan1200-121212Mining and analysis of adverse events of bevacizumab in ovarian cancer patients based on FAERS databaseGAO Meng, WU Yu-pei, WANG Miao-miao, WU Hui-zhen1213-122113Signal mining and analysis of adverse drug events of raltegravir and dolutegravir based on the FAERS databaseGU Jia-hui, ZHAO Jian-qun, CHEN Qing-yu, CAO Yan-li, MA Yin-ling1222-1232 